According to Stratistics MRC, the “Global Single-Use Assemblies” is accounted for $680.47 million in 2018 and is expected to reach $3,087.98 million by 2027 growing at a CAGR of 18.3% during the forecast period. Increasing demand for biopharmaceuticals, rapid implementation, and rising life science R&D expenditure are the key factors driving the market growth. However, issues related to extractable & leachable is hindering the market growth.
Single-use assemblies are self-contained and preassembled plastic fluid paths, usually, gamma-irradiated for sterility and ready-to-use, built from a combination of standard components. Single-use assemblies can be customized to meet defined applications and unit operations. Components used for fluid management are individual parts designed to perform a particular function when assembled into the Single-use systems (SUSs).
Browse the full report at: “Global Single-Use Assemblies”
Global Single-Use Assemblies market is segmented by solution into Customized Solution and Standard Solution. Based on the solution, standard solutions are expected to show significant growth during the forecast period. Due to the manufacturing process efficiency with reduced capital costs, improved flexibility with the use of pre-qualified components for building assemblies, reduced implementation time, and more flexibility with production planning are some of the advantages offered by standard solutions. This, in turn, is expected to drive the demand for a standard solution.
Global Single-Use Assemblies market is fragmented by-product into Mixing System Assemblies, Filtration Assemblies, Bag Assemblies, Bottle Assemblies, and Other Products. On the basis of the product, the bag assembly segment is projected to grow at a considerable rate during the forecast period as it enables critical liquid handling in bio-manufacturing and eliminates the time & cost of additional cleaning and sterilization, system set-up, maintenance, and validation.
Global Single-Use Assemblies market is segregated by application into Storage, Fill-Finish application, Filtration, Cell Culture and Mixing, Sampling, and Other Applications. Depending on the application, filtration is expected to show the substantial growth in the forecast period owing to the reduced work for column cleaning, sterilization and packing, and simplified validation and cleaning.
Increasing adoption of filtration assemblies due to surety that operators do not come in contact with cleaning solutions, cytotoxic fluids, or buffers with extreme pH, and thus provide safety. This provides not only economic benefits but also safety and time-to-market advantages.
Global Single-Use Assemblies market is bifurcated by end-user into Contract Research Organizations & Contract Manufacturing Organizations, Biopharmaceutical,\and Pharmaceutical Companies, and Academic & Research Institutes Amongst the end-user, the biopharmaceutical and pharmaceutical companies are projected to register the significant growth rate during the forecast period due to the reduced capital costs, improving plant flexibility, reducing start-up times and costs, and eliminating the risk of cross-contamination. Also, assembly components can be easily connected with the existing set-up.
To request for customization, sample fill in the Inquiry form at: “Global Single-Use Assemblies”
This report also covers trends driving each segment and offers analysis by geography, with key regions such as North America, Europe, Asia Pacific, South America, and Middle East & Africa. By geography, North America is expected to have a lucrative growth during the forecast period, due to the presence of a well-established biopharmaceutical industry in the region has created significant demand for single-use assemblies, low risk of contamination and low implementation costs, their adoption in biopharmaceutical companies for R&D are driving the growth of the market in North America.
Some of the key players profiled in the Single-Use Assemblies include Merck Millipore, Avantor, Inc., Thermo Fisher Scientific, Saint-Gobain, Danaher Corporation, GE Healthcare, Sartorius Stedim Biotech, Parker Hannifin Corporation, Corning Incorporated, Repligen Corporation, Lonza, and Entegris.
Contact:
JamesLamb
CorporateSalesSpecialist
UnitedStatesDirect:+1-301-202-5929
Email: sales@strategymrc.com
